Literature DB >> 22390753

Triaging women with ovarian masses for surgery: observational diagnostic study to compare RCOG guidelines with an International Ovarian Tumour Analysis (IOTA) group protocol.

B Van Calster1, D Timmerman, L Valentin, A McIndoe, S Ghaem-Maghami, A C Testa, I Vergote, T Bourne.   

Abstract

OBJECTIVE: To compare guidelines from the Royal College of Obstetricians and Gynaecologists (RCOG) based on the Risk of Malignancy Index (RMI) with a protocol based on logistic regression model LR2 developed by the International Ovarian Tumour Analysis (IOTA) group for triaging women with an ovarian mass as low, moderate, or high risk of malignancy. DESIGN AND
SETTING: Observational diagnostic study conducted between 2005 and 2007 at 21 oncology referral centres, referral centres for ultrasonography and general hospitals. SAMPLE: In all, 1938 women undergoing surgery for an ovarian mass.
METHODS: RCOG guidelines use the RMI to triage women as low (RMI < 25), moderate (25-250), or high (above >250) risk. The IOTA protocol uses LR2s estimated probability of malignancy (<0.05 indicates low risk, ≥ 0.05 but <0.25 moderate risk, and ≥ 0.25 high risk). MAIN OUTCOME MEASURE: Percentages of benign, borderline and invasive tumours classified as low, moderate or high risk.
RESULTS: The IOTA and RCOG protocols classified 71.1% and 62.1% of benign tumours as low risk, respectively (difference 9.0; 95% CI 6.2-11.9, P < 0.0001). Of invasive tumours, 88.6% and 73.6% were labelled high risk (difference 15.0; 10.6-19.4, P < 0.0001), and 3.0% and 5.2% were labelled low risk (difference -2.2; -4.6 to 0.2, P = 0.07) respectively by each protocol. Similar results were found after stratification for menopausal status.
CONCLUSIONS: The IOTA protocol was more accurate for triage than the RCOG protocol. The IOTA protocol would avoid major surgery for more women with benign tumours while still appropriately referring more women with an invasive tumour to a gynaecological oncologist.
© 2012 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2012 RCOG.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22390753     DOI: 10.1111/j.1471-0528.2012.03297.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  14 in total

Review 1.  Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.

Authors:  Sinead H McEvoy; Stephanie Nougaret; Nadeem R Abu-Rustum; Hebert Alberto Vargas; Elizabeth A Sadowski; Christine O Menias; Fuki Shitano; Shinya Fujii; Ramon E Sosa; Joanna G Escalon; Evis Sala; Yulia Lakhman
Journal:  Abdom Radiol (NY)       Date:  2017-10

Review 2.  Multimodality imaging review of complex pelvic lesions in female pelvis.

Authors:  Anuradha Chandramohan; Tameem Ahmed Bhat; Reetu John; Betty Simon
Journal:  Br J Radiol       Date:  2020-09-04       Impact factor: 3.039

3.  Risk of Malignancy Index (RMI) in Evaluation of Adnexal Mass.

Authors:  Rujuta Javdekar; Nandita Maitra
Journal:  J Obstet Gynaecol India       Date:  2014-10-07

4.  Towards an evidence-based approach for diagnosis and management of adnexal masses: findings of the International Ovarian Tumour Analysis (IOTA) studies.

Authors:  J Kaijser
Journal:  Facts Views Vis Obgyn       Date:  2015

5.  ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update.

Authors:  Rosemarie Forstner; Isabelle Thomassin-Naggara; Teresa Margarida Cunha; Karen Kinkel; Gabriele Masselli; Rahel Kubik-Huch; John A Spencer; Andrea Rockall
Journal:  Eur Radiol       Date:  2016-10-21       Impact factor: 5.315

6.  A new scoring model for characterization of adnexal masses based on two-dimensional gray-scale and colour Doppler sonographic features.

Authors:  A M Abbas; K M Zahran; A Nasr; H S Kamel
Journal:  Facts Views Vis Obgyn       Date:  2014

7.  Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study.

Authors:  A Testa; J Kaijser; L Wynants; D Fischerova; C Van Holsbeke; D Franchi; L Savelli; E Epstein; A Czekierdowski; S Guerriero; R Fruscio; F P G Leone; I Vergote; T Bourne; L Valentin; B Van Calster; D Timmerman
Journal:  Br J Cancer       Date:  2014-06-17       Impact factor: 7.640

Review 8.  Update on Imaging of Ovarian Cancer.

Authors:  Rosemarie Forstner; Matthias Meissnitzer; Teresa Margarida Cunha
Journal:  Curr Radiol Rep       Date:  2016-04-09

9.  Reliability of preoperative evaluation of postmenopausal ovarian tumors.

Authors:  Riikka Johanna Niemi; Sami Kristian Saarelainen; Tiina Hannele Luukkaala; Johanna Unelma Mäenpää
Journal:  J Ovarian Res       Date:  2017-03-14       Impact factor: 4.234

10.  Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) Score for Risk Stratification of Sonographically Indeterminate Adnexal Masses.

Authors:  Isabelle Thomassin-Naggara; Edouard Poncelet; Aurelie Jalaguier-Coudray; Adalgisa Guerra; Laure S Fournier; Sanja Stojanovic; Ingrid Millet; Nishat Bharwani; Valerie Juhan; Teresa M Cunha; Gabriele Masselli; Corinne Balleyguier; Caroline Malhaire; Nicolas F Perrot; Elizabeth A Sadowski; Marc Bazot; Patrice Taourel; Raphaël Porcher; Emile Darai; Caroline Reinhold; Andrea G Rockall
Journal:  JAMA Netw Open       Date:  2020-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.